Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Covant Therapeutics
Covant Therapeutics
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
Marketscreener
Tue, 03/28/23 - 10:20 am
Covant Therapeutics
drug discovery
R&D
Boehringer Ingelheim
cancer
ADAR1